Skip to main content

Emergency Provisions

PH-Unique · FDA declared emergencies · 15-day issuance rule

FDA Declared Public Health Emergencies​

The FDA Philippines has authority to declare a public health emergency for specific health threats, which triggers special provisions for medical device access. During a declared emergency:

  • Standard registration timelines may be shortened
  • Emergency use authorisations can be granted for devices not yet registered
  • The PFDA (Philippine FDA) Crisis Management Committee coordinates emergency response

PFDA Crisis Management Committee — PH-Unique​

The PFDA Crisis Management Committee is convened to manage the FDA Philippines' response to public health emergencies (disease outbreaks, disaster situations, public health crises). The Committee:

  • Coordinates expedited evaluation and approval of critical devices
  • Develops emergency guidelines for device access during crises
  • Interfaces with DoH and other government agencies on regulatory response
  • Reviews applications for emergency use under emergency conditions

Emergency Guidelines — 15-Day Issuance Rule — PH-Unique​

During a declared emergency, the FDA Philippines is required by the emergency framework to issue emergency authorisation guidelines within 15 days of the emergency declaration. This provision:

  • Forces rapid regulatory response during crises
  • Provides a known timeline for industry to plan emergency supply
  • Covers both newly manufactured emergency devices and expedited import of registered devices

Historical context: The COVID-19 pandemic demonstrated this provision in practice — Philippine FDA issued emergency use authorisations for critical diagnostics, PPE, and ventilators under expedited timeframes.

Emergency Access — Practical Implications​

For device manufacturers supplying the Philippines during an emergency:

  1. Monitor FDA Philippines announcements for emergency declarations affecting your device category
  2. Emergency guidelines will specify what documentation is required for expedited authorisation
  3. The 15-day guideline issuance requirement means the regulatory pathway becomes clear quickly
  4. CDRRHR will communicate directly with major suppliers and healthcare institutions during crises

Non-Emergency Expedited Access​

Outside of declared emergencies, the Philippines does not have a broadly available compassionate use or named-patient access mechanism comparable to some other markets. The primary expedited pathway is the Abridged Route (FDA Circular 2022-008) — see Abridged Pathway.

Importation Control During Emergencies​

The Bureau of Customs implements special importation procedures during declared public health emergencies to facilitate rapid entry of critical medical devices, coordinated with CDRRHR and the DoH.